Ovarian Cancer [clinicaltrials_resource:2d1991520f97240bef36628d464cec76]
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [clinicaltrials:NCT00001302]A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [clinicaltrials:NCT00001383]Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease [clinicaltrials:NCT00001503]Methods in Education for Breast Cancer Genetics [clinicaltrials:NCT00001806]Vinorelbine and XR9576 to Treat Cancer [clinicaltrials:NCT00001944]Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer [clinicaltrials:NCT00002474]Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer [clinicaltrials:NCT00002477]Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [clinicaltrials:NCT00002478]Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer [clinicaltrials:NCT00002485]Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors [clinicaltrials:NCT00002489]Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors [clinicaltrials:NCT00002508]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [clinicaltrials:NCT00002538]clinicaltrials:NCT00002558Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [clinicaltrials:NCT00002559]Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer [clinicaltrials:NCT00002568]Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [clinicaltrials:NCT00002600]Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002641]Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer [clinicaltrials:NCT00002671]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00002734]Melphalan in Patients With Neoplastic Meningitis [clinicaltrials:NCT00002750]Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [clinicaltrials:NCT00002764]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [clinicaltrials:NCT00002894]Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00002895]Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [clinicaltrials:NCT00002901]Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer [clinicaltrials:NCT00002903]Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [clinicaltrials:NCT00002928]clinicaltrials:NCT00002931clinicaltrials:NCT00002943SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [clinicaltrials:NCT00002960]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer [clinicaltrials:NCT00003002]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [clinicaltrials:NCT00003072]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Ovarian Cancer [clinicaltrials_resource:2d1991520f97240bef36628d464cec76]
Bio2RDF identifier
2d1991520f97240bef36628d464cec76
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2d1991520f97240bef36628d464cec76
identifier
clinicaltrials_resource:2d1991520f97240bef36628d464cec76
title
Ovarian Cancer
@en
label
Ovarian Cancer [clinicaltrials_resource:2d1991520f97240bef36628d464cec76]
@en